Ads
related to: pfizer
Search results
FliRT, a group of COVID-19 variants, accounts for most US cases. How to stay safe
Delaware Online | The News Journal via Yahoo News· 5 hours agoWe anticipate the updated vaccines will be better at fighting currently circulating variants,” the...
Pfizer Follows Eli Lilly's Footsteps To Sell Medicines Directly To Patients
Benzinga via Yahoo Finance· 4 days agoPfizer Inc (NYSE:PFE) is looking to build on the success of its COVID-19 vaccine rollout by...
Pfizer Stock Is Near An 11-Year Low — But Is It A Buy On This 'Massive' Upside?
Investor's Business Daily· 3 days agoPfizer stock jumped to its 50-day moving average in early May after the company beat first-quarter...
Pfizer Inc. Just Beat EPS By 61%: Here's What Analysts Think Will Happen Next
Simply Wall St. via Yahoo Finance· 7 days agoPfizer Inc. (NYSE:PFE) just released its first-quarter report and things are looking bullish. It was...
Want $1,000 in Dividend Income? Here's How Much You'd Have to Invest in Pfizer Stock | The Motley...
The Motley Fool· 5 days agoPfizer (PFE -0.21%) stock has struggled over the past year, losing around 28% of its value. Its...
Pfizer offers up to $250 million to settle thousands of Zantac cancer lawsuits, FT reports
WSAU Wausau· 2 days ago(Reuters) - Pfizer has agreed offer payment of up to $250 million to settle more than 10,000...
NHS introduces Pfizer’s tafamidis for ATTR-CM treatment
Pharmaceutical Technology via Yahoo Finance· 4 days agoThe UK's National Health Service (NHS) has introduced Pfizer's tafamidis for transthyretin...
Pfizer offers up to $250 million to settle Zantac cancer lawsuits, FT reports By Reuters
Investing.com· 2 days agoThe drugmaker was set to pay between $200 million and $250 million in the settlement, the newspaper...
The Zacks Analyst Blog Highlights Amazon, Visa, Pfizer, Martin Marietta Materials and Zimmer Biomet
Zacks via Yahoo Finance· 5 days agoStocks recently featured in the blog include: Amazon.com, Inc. AMZN, Visa Inc. V, Pfizer Inc. PFE,...
Arbutus urged to halt share issuances amid patent disputes By Investing.com
Investing.com· 10 hours ago(NASDAQ: NASDAQ:ABUS), has publicly urged the biopharmaceutical company to stop issuing shares to...